EYA2 promotes lung cancer cell proliferation by downregulating the expression of PTEN
Metrics: PDF 543 views | HTML 1062 views | ?
Zhaoming Li1, Ran Qiu2, Xia Qiu3 and Tian Tian4
1Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
2Wuhan Institute of Bioengineering, Wuhan, China
3Department of Medicine, Shangqiu Medical School, Shangqiu, China
4Department of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
Tian Tian, email: firstname.lastname@example.org
Keywords: EYA2; PTEN; lung cancer; cell proliferation; prognosis
Received: September 04, 2017 Accepted: October 29, 2017 Published: December 02, 2017
Lung cancer is the leading cause of cancer-related death worldwide. Despite advances have been made in diagnosis and therapeutic strategies, the prognosis of lung cancer is still very poor. Eyes absent transcriptional cofactor EYA2 has been shown to promote lung cancer cell growth, however, the underlying molecular mechanism is still not fully understood. In the present study, we found that EYA2 was up-regulated in lung cancer, and EYA2 led to increased cell proliferation by inhibiting Phosphatase and tensin homologue (PTEN) expression via modulation of miR-93. Additionally, survival analysis showed that lung cancer patients with higher EYA2 expression predicted a worse prognosis. Therefore, these findings demonstrate that EYA2 may play an important role in lung cancer occurrence and progression. Targeting EYA2 may provide a feasible approach in developing novel anticancer therapeutics.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.